We are live on ! Find out more
PA

Perceptive Advisors Portfolio holdings

AUM $6.66B
1-Year Est. Return 360.84%
This Fund
S&P 500
This Quarter Est. Return
+59.82%
1 Year Est. Return
+360.84%
3 Year Est. Return
+1,707.27%
5 Year Est. Return
+3,210.42%
10 Year Est. Return
+53,055.89%
AUM
$1.55B
AUM Growth
+$107M
Cap. Flow
-$72.8M
Cap. Flow %
-4.7%
Top 10 Hldgs %
49.99%
Holding
236
New
61
Increased
26
Reduced
57
Closed
43

Top Buys

Rank Stock Value
1
KDMN
Kadmon Holdings, Inc.
KDMN
+$20.1M
2
AVDL
Avadel Pharmaceuticals
AVDL
+$17.8M
3
RDUS
Radius Health, Inc.
RDUS
+$15.9M
4
ARAV
Aravive, Inc. Common Stock
ARAV
+$14.4M
5
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
+$13.6M

Top Sells

Rank Stock Value
1
MDVN
MEDIVATION, INC.
MDVN
+$45.8M
2
TSRO
TESARO, Inc.
TSRO
+$43.1M
3
NVRO
NEVRO CORP.
NVRO
+$31.9M
4
CPXX
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
+$25.3M
5
STJ
St Jude Medical
STJ
+$18.2M

Sector Composition

Rank Sector Weight
1 Healthcare 96.62%
2 Miscellaneous 2.58%
3 Consumer Staples 0.5%
4 Technology 0.1%
5 Consumer Discretionary 0.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UHS icon
126
Universal Health Services
UHS
$10.4B
$492K 0.03%
3,989
– –
SGYP
127
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$491K 0.03%
+89,127
New +$417K
AMAG
128
DELISTED
AMAG Pharmaceuticals
AMAG
$479K 0.03%
+19,524
New +$488K
MGLN
129
DELISTED
Magellan Health Services, Inc.
MGLN
$471K 0.03%
8,772
– –
HCA icon
130
HCA Healthcare
HCA
$91.8B
$469K 0.03%
6,202
– –
CRL icon
131
Charles River Laboratories
CRL
$13B
$457K 0.03%
5,482
– –
UNH icon
132
UnitedHealth
UNH
$337B
$452K 0.03%
3,231
– –
LNTH icon
133
Lantheus
LNTH
$6.58B
$445K 0.03%
+53,763
New +$356K
AMSG
134
DELISTED
Amsurg Corp
AMSG
$444K 0.03%
+6,618
New +$462K
AFAM
135
DELISTED
Almost Family Inc
AFAM
$439K 0.03%
11,942
– –
KND
136
DELISTED
Kindred Healthcare
KND
$432K 0.03%
42,301
– –
AMN icon
137
AMN Healthcare
AMN
$1.32B
$428K 0.03%
13,445
– –
ELV icon
138
Elevance Health
ELV
$90.6B
$426K 0.03%
3,400
– –
IQV icon
139
IQVIA
IQV
$44.4B
$414K 0.03%
+5,103
New +$386K
GRCE
140
Grace Therapeutics
GRCE
$46.9M
$414K 0.03%
4,928
– –
STLA icon
141
Stellantis
STLA
$14.8B
$397K 0.03%
62,248
– –
THC icon
142
Tenet Healthcare
THC
$21B
$367K 0.02%
16,200
– –
ENZ
143
DELISTED
Enzo Biochem, Inc.
ENZ
$342K 0.02%
67,113
– –
RACE icon
144
Ferrari
RACE
$71.5B
$322K 0.02%
6,200
– –
MNK
145
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$314K 0.02%
+4,500
New +$326K
ONSIW
146
DELISTED
Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019
ONSIW
$313K 0.02%
656,382
+193,882
+42% +$88.2K
MACK
147
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$311K 0.02%
6,216
-139
-2% -$5.77K
AH
148
DELISTED
Accretive Health
AH
$305K 0.02%
+125,000
New +$305K
TDOC icon
149
Teladoc Health
TDOC
$1.2B
$275K 0.02%
+15,000
New +$263K
GNVC
150
DELISTED
GenVec, Inc.
GNVC
$259K 0.02%
56,132
-4,532
-7% -$26.1K
4 5
6
7 8

Similar funds

QP
Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return
FCBT
First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return
RWM
Ritholtz Wealth Management New York $6.7B AUM 32.7% 1-Year Est. Return
AWA
Arkadios Wealth Advisors Atlanta, Georgia $6.6B AUM 30.67% 1-Year Est. Return
WHRC
W.H. Reaves & Co Jersey City, New Jersey $6.59B AUM 31.9% 1-Year Est. Return
KGA
K5 Global Advisor Miami Beach, Florida $6.59B AUM
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $6.74B AUM 30.22% 1-Year Est. Return

Perceptive Advisors's Q3 2016 Portfolio in Review

As of Q3 2016, Perceptive Advisors held 236 positions worth $1.55B, up 7.4% from $1.44B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Perceptive Advisors withdrew a net $72.8M in Q3 2016, closing 43 positions and reducing 57 holdings. Its most notable exit was MEDIVATION, INC., an estimated $45.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 97% of assets, up from 79% a quarter earlier, followed by Miscellaneous and Consumer Staples.

Against the trend, Perceptive Advisors opened a new position in Kadmon Holdings, Inc. worth $16.2M.

  • Perceptive Advisors's largest Q3 2016 buy was Kadmon Holdings, Inc.: 2,209,657 shares worth $16.2M.
  • Perceptive Advisors added most to Aravive, Inc. Common Stock in Q3 2016, an estimated $14.4M increase.
  • Perceptive Advisors's biggest Q3 2016 reduction was TESARO, Inc., cutting an estimated $43.1M.
  • Perceptive Advisors fully exited MEDIVATION, INC. in Q3 2016, selling an estimated $45.8M.
  • Perceptive Advisors's ten largest holdings make up 50% of its $1.55B portfolio in Q3 2016.
  • Perceptive Advisors opened 61 new positions and closed 43 in Q3 2016.
  • Perceptive Advisors's portfolio value rose 7.4% quarter-over-quarter to $1.55B.

Based on Perceptive Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.